MENU
+Compare
CAPR
Stock ticker: NASDAQ
AS OF
Dec 23, 11:24 AM (EDT)
Price
$12.92
Change
-$0.15 (-1.15%)
Capitalization
594.75M

CAPR Capricor Therapeutics Forecast, Technical & Fundamental Analysis

Develops innovative products for the treatment of cardiovascular diseases

Industry Biotechnology
CAPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for CAPR with price predictions
Dec 20, 2024

CAPR's RSI Oscillator climbs out of oversold territory

The RSI Oscillator for CAPR moved out of oversold territory on December 05, 2024. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 29 similar instances when the indicator left oversold territory. In of the 29 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CAPR advanced for three days, in of 265 cases, the price rose further within the following month. The odds of a continued upward trend are .

CAPR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 03, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on CAPR as a result. In of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

CAPR moved below its 50-day moving average on December 03, 2024 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CAPR crossed bearishly below the 50-day moving average on December 04, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CAPR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CAPR entered a downward trend on December 06, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CAPR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.703) is normal, around the industry mean (14.556). P/E Ratio (0.000) is within average values for comparable stocks, (87.563). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.739). CAPR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (17.857) is also within normal values, averaging (256.215).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
CAPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CAPR is expected to report earnings to fall 42.11% to -21 cents per share on March 06

Capricor Therapeutics CAPR Stock Earnings Reports
Q4'24
Est.
$-0.22
Q3'24
Missed
by $0.02
Q2'24
Beat
by $0.01
Q1'24
Missed
by $0.08
Q4'23
Beat
by $0.07
The last earnings report on November 13 showed earnings per share of -37 cents, missing the estimate of -36 cents. With 91.77K shares outstanding, the current market capitalization sits at 594.75M.
A.I. Advisor
published General Information

General Information

Develops innovative products for the treatment of cardiovascular diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
10865 Road to the Cure
Phone
+1 858 727-1755
Employees
102
Web
https://www.capricor.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCIGX33.900.32
+0.95%
Fidelity Advisor Small Cap Growth I
SCVNX37.590.22
+0.59%
Allspring Small Company Value Inst
RYMGX49.610.16
+0.32%
Rydex S&P MidCap 400 Pure Growth A
IEMGX9.460.01
+0.11%
Voya Multi-Manager Emerging Markets Eq I
GGFPX13.85-0.04
-0.29%
Goldman Sachs Intl Eq Insghts P

CAPR and Stocks

Correlation & Price change

A.I.dvisor tells us that CAPR and SRPT have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CAPR and SRPT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAPR
1D Price
Change %
CAPR100%
+1.32%
SRPT - CAPR
32%
Poorly correlated
-0.42%
MDGL - CAPR
30%
Poorly correlated
+5.12%
CORT - CAPR
30%
Poorly correlated
+0.49%
RCKT - CAPR
29%
Poorly correlated
+1.85%
SLNO - CAPR
28%
Poorly correlated
-0.04%
More